Creation of piroxicam nanoform

The first clinical trial of Nanoform Piroxicam manuractured by the Finnish company will begin at the end of 2020.

Paroxetine may have anti-cancer effects

Scientists from Sweden Karolinska Institute have found that a common and often prescribed antidepressant can stop the growth of a malignant tumor.

Staphylococcus aureus may be a cure

Scientists have discovered a bacterial toxin that promotes tissue healing.

Osteoporosis. ACR novelties within the framework of the rheumatology school

The company "Ananta Medicare" supported the holding of the rheumatology school and took part in it. More than 1,500 doctors have got acquainted with the materials of the school remotely.

Antibiotics can treat dementia

Scientists from the United States have found that a certain class of antibiotics could be promising for the treatment of frontotemporal dementia.

New toxoplasmosis vaccine

By using a new approach, scientists have developed an experimental vaccine against Toxoplasma gondii.

A two-vaccine regimen may provide the best protection against Ebola virus

A study has shown that sequential administration of two different Ebola virus vaccines at regular intervals may provide the best immune response.

EMA may approve new gene therapy product by Bluebird Bio Company

European Medicines Agency is considering the application of the American Bluebird Bio for the registration of cerebral adrenoleukodystrophy drug.